SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. The company’s most advanced lead is an aminoglycoside antibiotic that addresses the rapidly emerging resistant gram-negative hospital infection market. Genetic Chemistry is defining a new paradigm for drug discovery, offering significant technical and economic advantages, as well as expediency in product development.
Looking for a particular SelectX Pharmaceuticals employee's phone or email?
SelectX Pharmaceuticals Questions
The SelectX Pharmaceuticals annual revenue was $4 million in 2026.
Mark Nedelman is the Director, Business Development of SelectX Pharmaceuticals.
2 people are employed at SelectX Pharmaceuticals.
SelectX Pharmaceuticals is based in Worcester, Massachusetts.
The NAICS codes for SelectX Pharmaceuticals are [32, 32541, 325, 3254].
The SIC codes for SelectX Pharmaceuticals are [28, 283].
Top SelectX Pharmaceuticals Employees
-
Mark Nedelman
Director, Business Development at SelectX Pharmaceuticals
Massachusetts, United States22 -
Tao Liu
Staff Scientist at SelectX Pharmaceuticals
Worcester, MA, US22
Related Companies
